Suppr超能文献

成骨细胞通过Fas配体/FAS途径诱导破骨细胞凋亡是维持骨量所必需的。

Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.

作者信息

Wang L, Liu S, Zhao Y, Liu D, Liu Y, Chen C, Karray S, Shi S, Jin Y

机构信息

State Key Laboratory of Military Stomatology, Center for Tissue Engineering, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, China.

State Key Laboratory of Military Stomatology, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi 710032, China.

出版信息

Cell Death Differ. 2015 Oct;22(10):1654-64. doi: 10.1038/cdd.2015.14. Epub 2015 Mar 6.

Abstract

The interplay between osteoblasts and osteoclasts has a crucial role in maintaining bone homeostasis. In this study, we reveal that osteoblasts are capable of inducing osteoclast apoptosis by FAS ligand (FASL)/FAS signaling. Conditional knockout of FASL in osteoblasts results in elevated osteoclast numbers and activity, along with reduced bone mass, suggesting that osteoblast-produced FASL is required to maintain physiological bone mass. More interestingly, we show that osteoblasts from ovariectomized (OVX) osteoporotic mice exhibit decreased FASL expression that results from the IFN-γ- and TNF-α-activated NF-κB pathway, leading to reduced osteoclast apoptosis and increased bone resorption. Systemic administration of either IFN-γ or TNF-α ameliorates the osteoporotic phenotype in OVX mice and rescues FASL expression in osteoblasts. In addition, ovariectomy induces more significant bone loss in FASL conditional knockout mice than in control group with increased osteoclast activity in which the levels of RANKL and OPG remain unchanged. Taken together, this study suggests that osteoblast-induced osteoclast apoptosis via FASL/FAS signaling is a previously unrecognized mechanism that has an important role in the maintenance of bone mass in both physiological conditions and OVX osteoporosis.

摘要

成骨细胞与破骨细胞之间的相互作用在维持骨稳态中起着关键作用。在本研究中,我们发现成骨细胞能够通过FAS配体(FASL)/FAS信号通路诱导破骨细胞凋亡。成骨细胞中FASL的条件性敲除导致破骨细胞数量和活性增加,同时骨量减少,这表明成骨细胞产生的FASL是维持生理骨量所必需的。更有趣的是,我们发现来自去卵巢(OVX)骨质疏松小鼠的成骨细胞表现出FASL表达降低,这是由IFN-γ和TNF-α激活的NF-κB途径所致,导致破骨细胞凋亡减少和骨吸收增加。全身给予IFN-γ或TNF-α可改善OVX小鼠的骨质疏松表型,并恢复成骨细胞中FASL的表达。此外,与RANKL和OPG水平保持不变但破骨细胞活性增加的对照组相比,去卵巢在FASL条件性敲除小鼠中诱导的骨丢失更为显著。综上所述,本研究表明成骨细胞通过FASL/FAS信号通路诱导破骨细胞凋亡是一种先前未被认识的机制,在生理条件和OVX骨质疏松症中骨量的维持中具有重要作用。

相似文献

1
Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass.
Cell Death Differ. 2015 Oct;22(10):1654-64. doi: 10.1038/cdd.2015.14. Epub 2015 Mar 6.
2
Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.
EMBO J. 2008 Feb 6;27(3):535-45. doi: 10.1038/sj.emboj.7601984. Epub 2008 Jan 24.
3
Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway.
PLoS One. 2015 Nov 16;10(11):e0142519. doi: 10.1371/journal.pone.0142519. eCollection 2015.
5
Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
J Bone Miner Res. 2005 Sep;20(9):1659-68. doi: 10.1359/JBMR.050503. Epub 2005 May 2.
7
Fas receptor is required for estrogen deficiency-induced bone loss in mice.
Lab Invest. 2010 Mar;90(3):402-13. doi: 10.1038/labinvest.2009.144. Epub 2010 Jan 18.
9
Mst2 Controls Bone Homeostasis by Regulating Osteoclast and Osteoblast Differentiation.
J Bone Miner Res. 2015 Sep;30(9):1597-607. doi: 10.1002/jbmr.2503. Epub 2015 May 31.
10
Osteoblast-osteoclast interactions.
Connect Tissue Res. 2018 Mar;59(2):99-107. doi: 10.1080/03008207.2017.1290085. Epub 2017 Mar 21.

引用本文的文献

1
The Role of Sirtuins in Bone Repair From the Perspective of Glucose Metabolism.
Int J Gen Med. 2025 Sep 1;18:5013-5031. doi: 10.2147/IJGM.S530523. eCollection 2025.
3
Estrogens protect bone mass by inhibiting NAD metabolism in osteoclasts.
bioRxiv. 2025 Jul 16:2025.07.11.664289. doi: 10.1101/2025.07.11.664289.
4
Topography-based implants for bone regeneration: Design, biological mechanism, and therapeutics.
Mater Today Bio. 2025 Jul 13;34:102066. doi: 10.1016/j.mtbio.2025.102066. eCollection 2025 Oct.
5
Aberrant Tryptophan Metabolism Manipulates Osteochondral Homeostasis.
Research (Wash D C). 2025 Jun 10;8:0728. doi: 10.34133/research.0728. eCollection 2025.
6
Sex-dependent variation in bone adaptation: from degeneration to regeneration.
J Orthop Translat. 2025 May 5;52:325-343. doi: 10.1016/j.jot.2025.04.011. eCollection 2025 May.
8
Biomaterial Cues for Regulation of Osteoclast Differentiation and Function in Bone Regeneration.
Adv Ther (Weinh). 2025 Jan;8(1). doi: 10.1002/adtp.202400296. Epub 2024 Nov 15.
10
's role in RANKL-induced osteoclast differentiation: insights from a bone marrow macrophage model.
PeerJ. 2024 Oct 9;12:e18222. doi: 10.7717/peerj.18222. eCollection 2024.

本文引用的文献

2
CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance.
Nature. 2013 Mar 14;495(7440):227-30. doi: 10.1038/nature11926. Epub 2013 Feb 24.
3
ERα signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis.
J Bone Miner Res. 2013 Feb;28(2):283-90. doi: 10.1002/jbmr.1747.
4
Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis.
Cell Stem Cell. 2012 May 4;10(5):544-55. doi: 10.1016/j.stem.2012.03.007. Epub 2012 Apr 26.
5
Osteoprotection by semaphorin 3A.
Nature. 2012 May 3;485(7396):69-74. doi: 10.1038/nature11000.
8
Suppression of bone formation by osteoclastic expression of semaphorin 4D.
Nat Med. 2011 Oct 23;17(11):1473-80. doi: 10.1038/nm.2489.
9
New targets for intervention in the treatment of postmenopausal osteoporosis.
Nat Rev Rheumatol. 2011 Sep 20;7(11):631-8. doi: 10.1038/nrrheum.2011.130.
10
Evidence for osteocyte regulation of bone homeostasis through RANKL expression.
Nat Med. 2011 Sep 11;17(10):1231-4. doi: 10.1038/nm.2452.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验